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Objectives The purpose of this study was to define the incidence and characterization of cardiovascular cause of sudden
death in the young.
Background The epidemiology of sudden cardiac death (SCD) in young adults is based on small studies and uncontrolled observa-
tions. Identifying causes of sudden death in this population is important for guiding approaches to prevention.
Methods We performed a retrospective cohort study using demographic and autopsy data from the Department of Defense
Cardiovascular Death Registry over a 10-year period comprising 15.2 million person-years of active surveillance.
Results We reviewed all nontraumatic sudden deaths in persons 18 years of age and over. We identified 902 subjects in
whom the adjudicated cause of death was of potential cardiac etiology, with a mean age of 38  11 years. The
mortality rate for SCD per 100,000 person-years for the study period was 6.7 for males and 1.4 for females
(p  0.0001). Sudden death was attributed to a cardiac condition in 715 (79.3%) and was unexplained in 187
(20.7%). The incidence of sudden unexplained death (SUD) was 1.2 per 100,000 person-years for persons 35
years of age, and 2.0 per 100,000 person-years for those 35 years of age (p  0.001). The incidence of fatal
atherosclerotic coronary artery disease was 0.7 per 100,000 person-years for those 35 years of age, and 13.7
per 100,000 person-years for those 35 years of age (p  0.001).
Conclusions Prevention of sudden death in the young adult should focus on evaluation for causes known to be associated
with SUD (e.g., primary arrhythmia) among persons 35 years of age, with an emphasis on atherosclerotic
coronary disease in those 35 years of age. (J Am Coll Cardiol 2011;58:1254–61) © 2011 by the American
College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.049Sudden death of the healthy young adult is uncommon, but
receives substantial attention from the media and raises
issues of accountability for screening programs (1). The
From the *Brooke Army Medical Center, San Antonio, Texas; †Landstuhl Regional
Medical Center, Landstuhl, Germany; ‡Armed Forces Institute of Pathology,
Washington, DC; §Walter Reed Army Medical Center, Washington, DC; and the
Brigham & Women’s Hospital, Boston, Massachusetts. Dr. Appel is currently
affiliated with Northwestern University, Chicago, Illinois. Dr. Avedissian is currently
affiliated with Madigan Army Medical Center, Seattle, Washington. Dr. Pearse is
currently affiliated with the Uniformed Services University, Bethesda, Maryland. Dr.
Tremaine is currently affiliated with the Landstuhl Regional Medical Center,
Landstuhl, Germany. Dr. Gentlesk is currently affiliated with Cardiology Consultants
Ltd., Norfolk, Virginia. The opinions and research contained herein are the private
ones of the authors and are not to be considered as official or reflecting the views of
the Department of the Army or the Department of Defense. All authors have
reported that they have no relationships relevant to the contents of this paper to
disclose.Manuscript received November 22, 2010; revised manuscript received December
22, 2010, accepted January 31, 2011.relative importance of different etiologies of sudden death
varies among studies. Among cohorts collected using pas-
sive surveillance (e.g., newspaper accounts and Internet
queries), hypertrophic cardiomyopathy was the most com-
monly identified abnormality in sudden death of young
adults and young athletes (2–4). Passive surveillance meth-
ods are, however, subject to ascertainment and referral bias.
Studies utilizing active surveillance to collect all deaths in a
defined population, found by administrative diagnostic cod-
ing or death certificate review, have found either no iden-
tifiable structural abnormality or coronary artery disease
(CAD) in the majority of cases of sudden death (5–11).
Despite advances in defining the causes of sudden death
and dramatic developments in the ability to screen for
genetic diseases and premature atherosclerosis (12–24),
recommendations for screening the young, apparently
healthy adult have not changed over the past 4 decades.
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trocardiographic and molecular screening in select cases at
elevated risk (i.e., recurrent syncope, family history of
premature unexplained sudden death), the widespread util-
ity of these technologies is uncertain (12,14,25).
Military personnel provide a unique opportunity to ex-
amine the cause-specific nature of sudden death in an
ethnically heterogenous population. Each applicant to the
military undergoes a screening questionnaire with rejection
for hypertension, known structural heart disease, symptom-
atic arrhythmia, and most congenital anomalies (8). How-
ever, disqualification for cardiac or vascular system abnor-
malities is very rare, with an annual rate of disqualification
of 0.015% in the year 2000 (8). The military population is
unique in that the exact number of persons under examina-
tion is clearly identifiable; all health care, whether in or
outside of military health care systems is captured and
documented; and there is established centralization of all
autopsy reporting. Active surveillance in health and in
death, with routine performance of an autopsy, allows for
reduction of case referral bias, as might be seen in high-
profile cases with disproportionate media attention. We
describe the leading causes of death in this active surveil-
lance population.
Methods
The patient population included all uniformed personnel
from the Department of Defense. Anyone dying while on
active duty was included, from initial entry (i.e., recruits)
and those throughout active service, but excluding retired
personnel. All uniformed personnel, whether in a combat-
ant or support role, are required to maintain a level of both
physical fitness and weight control throughout active ser-
vice. The most recent demographics find that the popula-
tion under surveillance has an average age of 28.2 years and
is 84.0% male; and although not recorded before 2003, the
most recent accession data identified an entry population
that self-reported as 72.7% Caucasian, 15.0% African
American, 1.2% Pacific Islander, and 2.6% Asian.
For each death, a detailed report to include autopsy is
filed with the Armed Forces Institute of Pathology in
accordance with established protocol (26). Although not all
autopsies were performed at the Armed Forces Institute of
Pathology, in Washington, DC, the Office of the Armed
Forces Medical Examiner system appoints Regional Med-
ical Examiners, board certified in forensic examination by
the American Board of Pathology, to serve as worldwide
consultants. Nontraumatic deaths were identified through
the Department of Defense mortality registry. Cases were
eligible for review if they were categorized as sudden
unexplained deaths (SUD) or deaths due to the following
causes: cardiac, exertional heat illness, vascular, asthma, and
all exercise-related deaths not elsewhere classified. Demo-
graphic data and details surrounding the circumstances of
the fatal incident were obtained from the pathology reports,reports from the criminal inves-
tigative division, and available
antemortem medical records.
The records from each case
which met the inclusion criteria
were assembled and reviewed by
the authors. Adjudication of each
case by at least 3 authors was
performed, and a final determi-
nation was made as to clinical
cause of death. In no case was
there exclusion of a case due to
disagreement as to characteristics and etiology of death.
Sudden death was defined as an event resulting in death or
terminal life support within 1 h of collapse, or an unwit-
nessed but unexpected death in the absence of known or
suspected condition that may predispose to terminal illness.
Deaths were defined as cardiac in origin if there was autopsy
confirmed heart disease with clinical circumstances consis-
tent with a potential cardiac etiology of death (excluding, for
example, incidental cardiac disease in a patient who expe-
rienced traumatic death). SUD was defined as any sudden
death unexplained by pre-existing disease and without
identifiable cause on post-mortem examination.
Specific cardiac causes of sudden death were defined as
follows: atherosclerotic coronary artery disease (ASCAD)
was considered the cause when gross pathologic and/or
histopathologic findings indicated an acute or recent myo-
cardial infarction or occlusive ASCAD. Hypertrophic car-
diomyopathy was based on gross pathologic and histologic
findings consistent with the diagnosis (27,28), to include
nondilated left ventricular hypertrophy, in the absence of
coexistent disease that could cause in magnitude of hyper-
trophy evident. Myocarditis was based on histopathologic
diagnosis of inflammatory infiltrates in accordance with
Dallas criteria (29). Dilated cardiomyopathy was based on
left ventricular dilation in the absence of histologic changes
consistent with an inflammatory cardiac condition and in
the absence of CAD. Anomalous coronary arteries were
considered causative when specific anomalies known to be
associated with sudden death were noted on autopsy or a
coronary anomaly was the only finding. Those anomalies
felt to be associated with sudden death included any
anomalous left main coronary artery with take-off from the
right coronary cusp and a course between the pulmonary
artery and aorta, anomalous right coronary artery with
oblique take-off, and regional acute or chronic correspond-
ing regional perfusion defect. Separate coronary ostia, clo-
acal left main coronary artery, and anomalous circumflex off
the right coronary cusp were not considered to be causative
of sudden death. Hypertensive cardiomyopathy was based
on left ventricular hypertrophy or dilation in the setting of
known clinical hypertension. Arrhythmogenic right ventric-
ular dysplasia was based on gross pathologic and histologic
findings focusing on structural and histologic manifestations
Abbreviations
and Acronyms
ASCAD  atherosclerotic
coronary artery disease
CAD  coronary artery
disease
SCD  sudden cardiac
death(s)
SUD  sudden unexplained
death(s)(30). Ischemic heart disease was attributed as the cause of
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present.
Crude mortality rates are presented as deaths per 100,000
person-years (calculated by multiplying numeric death rates
[number of deaths per number of population] by period of
observation). Population data were obtained from the De-
fense Manpower Data Center (31). The annual variability of
the total population was3.9% with a standard deviation of
1.4% (maximum observed population 1.42 million annually,
minimum observed population 1.37 million annually, mean
1.39  0.02 million persons annually). Confidence intervals
or mortality rates were calculated by method of Poisson’s
istribution. Student t test was used for comparison of contin-
ous variables and the chi-square test for categorical variables.
ll p values were considered significant when 0.05. Statis-
ical analysis was performed using JMP Professional soft-
are (SAS Institute, Cary, North Carolina). The study was
pproved by the institutional review board, and sponsored
y a grant from the Air Force Medical Research Program
AF/SGRS).
esults
or the period from 1998 to 2008, there were 14,771 deaths
dentified. Of this population, 5,681 deaths were due to
ccidents, 3,811 were due to enemy hostile action, 478 were
he result of homicide, 1,997 were the result of suicide, and
5 were the result of terrorist attacks. Of the 2,729 remain-
ng cases, there were 1,044 nontraumatic suspected cardiac
eaths identified from 1998 to 2008. Of these, we excluded
1 (5.1%) subjects for lack of clinical record or autopsy, 130
12.5%) subjects for unavailability of records, and 12 (1.2%)
ubjects for what was determined to be a clear noncardiac
tiology. We identified 902 subjects with full records
vailable for review for whom the adjudicated cause of death
as of potential cardiac etiology, which serves as our cohort.
The mean age of the population was 38.4  10.5 years
median 39.6 years, interquartile range [25th, 75th percen-
iles]: 30.4, 45.9 years), and 871 male (96.6%). The mor-
ality rate for sudden cardiac death (SCD) per 100,000
erson-years for the study period was 6.68 (95% confidence
nterval: 6.24 to 7.14) for males and 1.40 (95% confidence
nterval: 0.95 to 1.98) for females (p  0.0001). As seen in
igure 1, mortality rates increased with age from 3.25 per
00,000 person-years for subjects 20 years of age, to
05.57 per 100,000 person-years for those50 years of age.
ortality rates were not statistically different for males and
emales under 20 years of age (p  0.084) or 20 to 24 years
f age (p 0.067), but point estimates were consistent with
trend for greater deaths among males. However, sudden
eath mortality rates were greater for males than for females
or all other age groups (p  0.01). Demographics of the
opulation are in Table 1. The population was predomi-
antly Caucasian, although African Americans were also
ell represented. Anthropometrics revealed that subjects
35 years of age weighed slightly more than those 35ears of age, but were no more likely to be considered either
verweight or obese using standard definitions (32).
ircumstances of sudden death. Death was witnessed in
17 (68.4%) cases, and verified as temporally associated with
xertion in 361 (40.0%) of witnessed cases, as seen in Table 2.
udden death during exertion was more common among
hose 35 years of age compared with those 35 years of
ge (140 of 298 [47.0%] vs. 221 of 604 [36.6%]; p 0.001).
he majority of exertional deaths were during recreational
ports. Sudden death during “military training” was almost
xclusively during organized physical training (138 of 150
92.0%]). While organized physical training includes a
ombination of calisthenics, strength-building exercises,
nd aerobic cardiovascular conditioning, in most cases, the
pecific activity at the time of death was not reported. The
ost commonly reported activity temporally related to
eath during organized physical training was running,
hich was reported in 114 (31.6%) of the exertional deaths.
Information was available on 528 (58.5%) subjects that
llowed for the definitive determination of presence or
bsence of any prodrome within the week before the
erminal event. A prodrome was documented in 278
52.7%) of those who died. Symptoms reported included
hest pain in 142 (51.8%), dyspnea in 61 (21.9%), and
yncope in 20 (7.2%). Further results as to outcome of
esting, if any, referable to identified prodrome was not
vailable, and in many cases, the prodrome was immediately
ntecedent to death.
Death was reported as out of the hospital (205 [22.7%]),
ithin the Emergency Department (462 [51.2%]) or after
dmission to the hospital (108 [12.0%]), and was otherwise
ot specified (107 [11.8%]). Of the 570 subjects transported
o the hospital, the initial cardiac rhythm was reported in
22 (21.4%) subjects. The reported rhythms included ven-
ricular fibrillation (62 [50.8%]), asystole (40 [32.8%]),
lectromechanical dissociation/pulseless electrical activity
11 [9.0%]), pathologic bradycardia (5 [4.1%]), and ventric-
lar tachycardia (4 [3.3%]). On-scene treatment was re-
orted to have occurred in 638 (70.7%), to include cardio-
ulmonary resuscitation in 605 (67.1%), attempted external
hock in 267 (29.6%), and documented care by an advanced
ardiac life support provider in 533 (59.1%).
auses of sudden death. Sudden death was attributed to
n identifiable structural cardiac finding in 715 (79.3%) and
as without structural abnormality identified (SUD) in 187
20.7%) (Tables 3 and 4). In subjects 35 years of age, the
eading cause of death was SUD (n  123 [41.3%]),
hereas in those 35 years of age, the leading cause of
eath was ASCAD (n  442 [73.2%]).
DEATH DUE TO ATHEROSCLEROTIC CORONARY DISEASE.
There were 511 deaths due to ASCAD, with a mean age of
43  8 years. The incidence of death due to ASCAD was
0.65 per 100,000 person-years for those 35 years of age,
and 13.69 per 100,000 person-years for those 35 years of
age (p  0.001). There were 206 (40.3%) deaths during
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[44.6%]) or recreational sports (n  81 [35.1%]). A pro-
drome was reported in 166 (32.4%) subjects, with chest pain
reported in 111 (21.7%), dyspnea in 27 (5.3%), palpitations
in 2 (0.4%), and syncope in 2 (0.4%).
Comparing sequential age groups of males, mortality
from atherosclerotic disease as a function of increasing age
group demonstrated no significant increase in mortality due
to atherosclerotic coronary disease until after age 30 years
(Fig. 1). There was a statistically significant increase in mor-
tality due to atherosclerotic coronary disease in each age group
beyond age 30 years, with a relative risk from 2.27 to 3.33 for
each 5-year period. Among females, mortality as a function of
increasing age group demonstrated no significant change in
mortality with each successive age group, but due to male
predominance in the sample, the analysis was under-powered.
Risk factors and known serologic levels of lipids are as
noted in Table 5. The mean total cholesterol at the time of
death from atherosclerosis was 215 mg/dl, with a mean
high-density lipoprotein cholesterol of 40 mg/dl. On au-
Figure 1 Mean Incidence of SCD as Function of Age, Stratified
Data table demonstrates incidence per 100,000 people under active surveillance,
diac death (SCD) in males (solid bars) to females (shaded bars). Additional inform
bars) as a function of age.topsy of subjects who died of atherosclerotic coronary vdisease, the mean cardiac mass was 457 77 g, with a mean
maximal left ventricular wall thickness of 1.6  0.4 cm.
here was evidence of remote myocardial infarction or
brosis in 156 (30.5%) cases, with suggestion of recent
yocardial infarction with ongoing necrosis in 50 (9.8%).
mong deaths due to ASCAD, the incidence of antemor-
em symptoms referable to cardiovascular disease was
6.1%.
DEATH DUE TO HYPERTROPHIC CARDIOMYOPATHY AND
HYPERTENSIVE CARDIOMYOPATHY. There were 83 subjects
ho died of either hypertrophic cardiomyopathy (n  57
6.3%]) or hypertensive cardiomyopathy (n  26 [2.9%]).
he mortality rate from hypertrophic cardiomyopathy was
.41 per 100,000 person-years, and from hypertensive car-
iomyopathy, it was 0.19 per 100,000 person-years.
There was no difference in the cardiac mass of subjects
ith death due to hypertrophic cardiomyopathy compared
o those with death due to hypertensive cardiomyopathy
501 77 g vs. 505 78 g, p 0.867), nor in maximal left
ex and Overall Incidence Due to ASCAD
e rate (RR) and 95% confidence interval (CI) comparing incidence of sudden car-
includes incidence of atherosclerotic coronary artery disease (ASCAD) (openby S
relativ
ationentricular thickness (2.0  0.4 cm vs. 1.9  0.3 cm, p 
1258 Eckart et al. JACC Vol. 58, No. 12, 2011
Active Surveillance of Sudden Death September 13, 2011:1254–610.466). Myofibrillary disarray was only positively identified
in 12.3% of cases diagnosed with hypertrophic cardiomy-
opathy. Hypertrophic cardiomyopathy was described in
reports most commonly as “asymmetric left ventricular
hypertrophy,” but also as “sigmoid septum in the setting of
biventricular hypertrophy” and “massive enlargement of in-
terventricular septum.” It is uncertain if these cases of
increased left ventricular mass represent a phenotypic vari-
ation of the more conventional hypertrophic cardiomyopa-
thy, and further research in this regard is intended (28).
Demographic and Clinical Characteristics of 902 Cases of Adjudicain a Cohort Undergo g Active Surveillance, Stratified by Age <35Table 1 Demographic and Clinical Charac eristics of 902 Casein a Cohort Undergoing Active Surveillance, Stratified
Characteristics
Total
(n  902)
Age, yrs 38 11
Race
Caucasian 608 (67.4%)
African American 217 (24.1%)
Pacific Islander 19 (2.1%)
Asian 17 (1.9%)
Male 871 (96.6%)
Anthropometrics
Height, inches [cm] 71 3 [180 8]
Weight, pounds [kg] 199 32 [91 15]
Body surface area, m2 2.12 0.20
BMI, kg/m2 28.3 4.2
Medical history
Overweight, BMI 25 kg/m2 427 (47.3%)
Obese, BMI 30 kg/m2 167 (18.5%)
Diabetes mellitus 10 (1.1%)
Hypertension 115 (12.8%)
Hyperlipidemia 99 (11.0%)
Values are mean  SD or n (%).
BMI  body mass index.
Specific Activities at Time ofEx rtional Sudd n Death in 361 Young AdultsTable 2 Specific Activities at Time ofExertional Sudden Death in 361 Young Adults
Recreational sports 186 (51.5%)
Running 114 (31.6%)
Basketball 20 (5.5%)
Walking 14 (3.9%)
Swimming 11 (3.0%)
Weightlifting 5 (1.4%)
Baseball 4 (1.1%)
Biking 4 (1.1%)
Military training 150 (41.6%)
Organized physical training* 138 (38.2%)
Road march/land navigation 7 (2.0%)
Miscellaneous 5 (1.4%)
Miscellaneous 17 (4.8%)
Not specified 8 (2.2%)
*Organized physical training defined as group-level activity to include performance of physical
fitness testing (sit-up, push-ups, and timed distance running). Additional recreational sports
representing1% included football (n 3), racquetball (n 3), soccer (n 3), volleyball (n 2),
hiking (n  1), paintball (n  1), and tennis (n  1). Miscellaneous causes included moving
furniture and/or equipment (n  8), mowing lawn (n  4), dancing (n  2), fighting (n  2), and
sexual intercourse (n  1).SUDDEN UNEXPLAINED DEATH. There were 187 sudden
deaths without identifiable alternative cause, representing
41.3% of all deaths of persons 35 years of age, and 10.6%
of all deaths of persons 35 years of age. There was no
statistically significant difference in the identification of
sudden unexplained death as a function of race (Caucasian
20.1%, African American 22.6%, Asian 23.5%, Pacific
nanticipated Sudden Cardiac Deaths or >35 Y arsdjudicated Unanticipated Sudden Cardiac Death
e <35 Years or >35 Years
<35 Yrs of Age
(n  298)
>35 Yrs of Age
(n  604) p Value
26 5 45 6 0.001
0.001
176 (59.1%) 432 (71.5%)
100 (33.6%) 117 (19.4%)
7 (2.4%) 12 (2.0%)
6 (2.0%) 11 (1.8%)
282 (94.6%) 589 (97.5%) 0.032
0 3 [178 8] 71 4 [180 10] 0.448
2 33 [87 15] 204 30 [93 14] 0.001
2.08 0.20 2.14 0.19 0.001
27.4 4.6 28.8 0.19 0.001
143 (48.0%) 284 (47.0%) 0.839
52 (17.5%) 115 (19.0%) 0.626
1 (0.3%) 9 (1.5%) 0.179
19 (6.4%) 96 (15.9%) 0.001
14 (4.7%) 85 (14.1%) 0.001
Cause-Specific Findings in 902 Cases ofAdjudicat d Unanticipated Sudden Cardiac DeathStratified by Age <35 Y ars and >35 Years in aohort Undergoi g Active Surveillance
Table 3
Cause-Specific Findings in 902 Cases of
Adjudicated Unanticipated Sudden Cardiac Death
Stratified by Age <35 Years and >35 Years in a
Cohort Undergoing Active Surveillance
Findings
<35 Yrs of Age
(n  298)
>35 Yrs of Age
(n  604) p Value
Sudden unexplained death 123 (41.3%) 64 (10.6%) 0.001
Atherosclerotic disease 69 (23.2%) 442 (73.2%) 0.001
Hypertrophic
cardiomyopathy
38 (12.8%) 19 (3.1%) 0.001
Myocarditis 17 (5.7%) 13 (2.2%) 0.009
Idiopathic dilated
cardiomyopathy
14 (4.7%) 21 (3.5%) 0.478
Anomalous coronary artery 12 (4.0%) 1 (0.2%) 0.001
Hypertensive
cardiomyopathy
11 (3.7%) 15 (2.5%) 0.419
Arrhythmogenic RV
dysplasia
4 (1.3%) 6 (1.0%) 0.737
Ischemic cardiomyopathy 2 (0.7%) 14 (2.3%) 0.135
Other* 8 (2.7%) 9 (1.5%) —
Data presented as raw (columnar percent [incidence]). *Other cases (n cases35 years of age,
cases 35 years of age, respectively): additional causes of death associated with coronary artery
disease included coronary artery bridge (n  6, 1), spontaneous coronary thrombosis (n  1, 2%)
and spontaneous coronary dissection (n  0, 1); causes of death associated with valvular heart
disease included aortic valve disease (n  0, 3), mitral valve disease (n  1, 1), and endocarditisted UY ars of A
by Ag
7
19(n  0, 1).
RV  right ventricle.
of exert
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incidence of prodrome comparing subjects with death due
to SUD (48.5%) and death due to ASCAD (56.1%, p 
0.231). Comparing subjects with sudden unexplained death
to those with death due to ASCAD, the incidence of
antemortem syncope or palpitations was 7.5% versus 2.2%,
respectively (p 0.002), and of chest pain or dyspnea, it was
4.3% versus 14.5% (p  0.001).
Discussion
This autopsy-based series, using active surveillance of pa-
tients in a defined population, found that sudden unex-
plained cardiac death, presumably arrhythmic, is the most
common cause among patients 35 years of age, and as
expected, atherosclerotic heart disease increases in impor-
tance over the age of 30 years, becoming the dominant
cause.
Active surveillance trials in studies using autopsy for
definitive diagnosis have previously suggested similar results
Leading Cause-Specific Findings in Adjudicated USud en rdiac Death Stratified by Age <35 Yean Exertional Status in a Cohort Undergoing A
Table 4
Leading Cause-Specific Fin ings in
Sudden Cardiac Death Stratified by
and Exertional Status in a Cohort U
<35
Findings
Exertional
(n  140)
Sudden unexplained death 54 (38.6%)
Atherosclerotic disease 34 (24.3%)
Hypertrophic cardiomyopathy 19 (13.6%)
Myocarditis 5 (3.6%)
Idiopathic dilated cardiomyopathy 2 (1.4%)
Anomalous coronary artery 11 (7.9%)
Data presented as raw (columnar percent [incidence]). Comparison
annotated (*p  0.001).
Demographic and Clinical Characteristics of the2 Leading Causes of Sudden C rdiac Death in902 Cases in Cohort Undergoing Active Surv illance
Table 5
Dem graphic a d Clinical Charact risti s of the
2 Leading Causes of Sudden Cardiac Death in
902 Cases in a Cohort Undergoing Active Surveillance
Characteristics
ASCAD
(n  511)
SUD
(n  187) p Value
Age, yrs 43 8 32 11 0.001
Age 35 yrs 69 (13.5%) 123 (65.8%) 0.001
Male 503 (98.4%) 174 (93.1%) 0.001
Medical history
Obese, BMI 30 kg/m2 99 (19.4%) 25 (13.4%) 0.084
Diabetes mellitus 11 (2.2%) 3 (1.6%) 0.770
Hypertension 137 (26.8%) 23 (12.3%) 0.001
Hyperlipidemia 156 (30.5%) 18 (9.6%) 0.001
Cholesterol screening 126 (24.6%) 40 (21.4%)
Total cholesterol 215 [184, 243] 182 [159, 216] 0.001
HDL 40 [34, 51] 47 [39, 60] 0.004
LDL 137 [112, 164] 116 [97, 140] 0.003
Triglycerides 134 [94, 215] 92 [55, 139] 0.001
Values are mean SD, n (%), or median [interquartile range at 25%, 75%], with comparisons done
using Mann-Whitney U test for nonparametricsASCAD  atherosclerotic coronary artery disease; BMI  body mass index; HDL  high-density
lipoprotein; LDL  low-density lipoprotein; SUD  sudden unexplained death.(6,8,9,33). In an Italian group studied from 1979 to 1999,
within an ethnically homogenous population of nearly 4.4
million, researchers found 300 cases of sudden death among
young adults (ages 12 to 35 years) who had undergone
screening by history, physical examination, electrocardio-
gram, and limited exercise testing (33). In this group, SUD
was the leading cause of death (25.6%), followed by athero-
sclerosis (20.9%) and arrhythmogenic right ventricular dys-
plasia (13.4%). Hypertrophic cardiomyopathy was found in
only 8.3% of cases. Likewise, in a smaller cohort in
Olmstead County, Minnesota, from 1960 to 1989, among
those 35 years of age with SCD (n  23), SUD (47.8%)
and atherosclerosis (34.8%) were the most common causes
of death (34). Previous work by our group using a cohort of
recruits (e.g., limited to those within the first 10 weeks of
initial entry to the military) found that in review of 6.3
million initial entry trainees from 1977 through 2001, there
were 126 sudden, nontraumatic deaths during training, with
no previously documented cardiovascular disease and no
known family history. In that population, with a median age
of 19 years, the leading causes of death were sudden
unexplained cardiac death (34.9%), or death related to
coronary pathology (30.9%) (8). In contrast to the present
study, prior work was limited to sudden deaths that oc-
curred specifically during initial entry training to the mili-
tary, whereas current work is not only more comprehensive
in period of observation, but is also more representative of
differing socioeconomic status. Doolan et al. (9) reported a
series of 10,199 autopsies in a region serving 2 million
persons in Australia; of 193 SCD in young adults, sudden
death occurred in the setting of a structurally normal heart
in 60 (31.1%), with the combination of hypertrophic car-
diomyopathy/unexplained left ventricular hypertrophy in 29
(15.0%). Similarly, utilizing a nationalized autopsy database
in Sweden, Wisten et al. (6) identified SUD in the setting
of a structurally normal heart in 38 (21.0%) and hypertro-
phic cardiomyopathy in 19 (10.5%). Thus, although sudden
unexplained cardiac death is consistently the most common
category of sudden death in young adults, work by Acker-
cipatednd >35 YearsSurv illanceated Unanticipated
<35 Years and >35 Years
going Active Surveillance
f Age >35 Yrs of Age
Nonexertional
(n  158)
Exertional
(n  221)
Nonexertional
(n  383)
69 (43.7%) 19 (8.6%) 45 (11.8%)
35 (22.2%) 172 (77.8%) 270 (70.5%)
19 (12.0%) 8 (3.6%) 11 (2.9%)
12 (7.6%) 1 (0.5%) 12 (3.1%)
12 (7.6%)* 5 (2.3%) 16 (4.2%)
1 (0.6%)* 0 (0.0%) 1 (0.3%)
ional versus nonexertional without statistical significance except asnantirs activedjudi
Age
nder
Yrs oman and Tester (23) have shown that more than one-third
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identifiable ion channel mutation.
There are several potential causes of SUD in our cohort.
First, we cannot exclude that structural abnormalities escape
detection in some cases, but given the intense search for a
cause, until we can pursue ultrastructural or molecular
disease as a course of clinical care, this will remain a
limitation to autopsy-based studies. Under-identified focal
myocarditis, mild right ventricle involvement with arrhyth-
mogenic right ventricular cardiomyopathy/dysplasia and
hypertrophic cardiomyopathy cannot be excluded, although
the methods allowed for a comprehensive identification.
Potential causes for death in an otherwise normal-appearing
heart may include an accessory pathway (i.e., Wolff-
Parkinson-White) with a rapid arrhythmia due to atrial
fibrillation, ion channel abnormalities including the
long-QT syndrome, short-QT syndrome, Brugada syn-
drome, catecholaminergic polymorphic ventricular tachy-
cardia, and early repolarization syndromes. Investigators
with the ORE-SUDS (Oregon Sudden Unexplained Death
Study) database (16) identified 12 patients who experienced
SUD, and potassium channel defects were identified in
17%. Genetic testing of kindred of those who experienced
SUD report as many as 40% with a mutation responsible for
catecholaminergic polymorphic ventricular tachycardia,
long-QT syndrome, Brugada syndrome, arrhythmogenic
right ventricular cardiomyopathy/dysplasia, hypertrophic
cardiomyopathy, or familial dyslipidemias (12,23,35).
Study limitations. By virtue of a military population, there
is risk of ascertainment bias. Although exclusion from
military service due to cardiovascular causes is extremely
rare, persons who pursue military training are not likely to
be experiencing symptoms that may be referable to cardio-
vascular disease, no different from self-selection of subjects
in athlete studies. Additionally, a person with a known
pre-existing disease state that might preclude participation
in strenuous athletic or military training may never join the
military and would, therefore, never come to the attention
of the investigators. That limits the generalizability of our
findings to persons with no known childhood disease state.
Mandated weight control and physical fitness standards may
limit the generalizability to groups with a similar lifestyle.
Additionally, there is the possibility that the adjudicated
cause of death was not representative of the mechanism of
death. Although autopsy reports and available records were
available in all included cases, there was no reexamination of
the originally submitted gross or histologic material beyond
that previously performed, and may or may not have been
originally performed by any of the authors.
Conclusions
Our findings suggest that prevention of sudden death
among young adults under the age of 35 years should focus
on evaluation for causes not associated with structural heart
disease, classified as SUD. There should be a continuedfocus on the prevention of atherosclerotic heart disease
starting at an age younger than that normally considered to
be at risk. Because symptoms referable to cardiovascular
disease were not commonly reported, lipid panels only
demonstrated small variations from the mean, and the
overall low risk profile of the patients experiencing events,
consistent with that of prior studies (36,37); newer risk
factors and advanced, safer imaging may be requisite
before we can make an impact on identifying persons at
risk for premature sudden death due to atherosclerosis.
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